Ta-VNS | Sham taVNS | No-treatment | |
---|---|---|---|
2hPG Baseline | 9.7 (1.2) | 9.1(1.2) | 9.3 (1.1) |
2hPG 6-weeks | 7.3 (1.8)** | 8.0 (1.6)** | 9.5 (1.9) |
2hPG 12-weeks | 7.5 (1.3)** | 8.0 (1.4)** | 10.0 (2.7) |
FPG Baseline | 6.2 (0.6) | 6.3 (0.5) | 6.5 (0.3) |
FPG 6-weeks | 5.9 (0.8)** | 6.2 (0.8) | 6.6 (0.8) |
FPG 12-weeks | 5.7 (0.6)** | 6.2 (0.8) | 6.9 (1.2) |
HbAlc Baseline | 6.3 (0.5) | 6.2 (0.6) | 6.2 (0.4) |
HBAlc 12-weeks | 6.1 (0.4)* | 6.0 (0.4)* | 6.3 (0.6) |
BMI Baseline | 24.5 (3.5) | 23.9 (2.6) | 25.7 (3.4) |
BMI 12-weeks | 24.1 (3.3) | 23.5 (2.6) | 25.4 (3.0) |